Try our Advanced Search for more refined results
Collegium Pharmaceutical, Inc. Post grant review
Case Number:
Case Type:
PGR
Status:
FWD Entered
Petitioner:
Collegium Pharmaceutical, Inc.
Patent Owner:
Tech Center:
-
Filed: March 13, 2018 00:00
Coverage
-
November 22, 2021
CORRECTED: PTAB Axes Patent After Purdue Ch. 11 Delay
The Patent Trial and Appeal Board has invalidated a Purdue Pharma patent for an opioid with an abuse deterrent, faulting the patent description and rejecting Purdue's argument that the board took too long to issue a decision.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the PTAB case documentsAlready a subscriber? Click here to login
-
November 22, 2021